Lineage Cell Therapeutics, Inc.
Why Is Lineage Cell Therapeutics, Inc. (LCTX) Stock Down Today?
Live update on LCTX's stock movement with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.
Summary
Lineage Cell Therapeutics, Inc. (LCTX) is trading down -1.52% at $1.30, reflecting a negative shift in investor sentiment today. The stock opened at $1.33 and has moved between $1.28 and $1.37 so far.
Trading volume is 763447, which is 39% below its average, and the price action suggests selling interest.
Technically, LCTX is trading below its 50-day moving average of $1.48 and below its 200-day moving average of $1.59, indicating short-term and long-term weakness.
Analyst sentiment is bullish. Meyka's AI assigns LCTX a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +33.85% in 1 month ($1.74), +85.85% in 1 year ($2.42), and +339.85% in 5 years ($5.72).
View the full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement.
Stay informed and make better investment decisions.
LCTX Technical Signals
Trading below 50-day moving average ($1.48)
Trading below 200-day moving average ($1.59)
Analyst Recommendations
Price Forecast
1 Month
$1.74
1 Year
$2.42
3 Years
$4.07
5 Years
$5.72
Is this change significant?
5-Day:+8.33%
1-Month:-16.13%
3-Month:-31.58%
What's next?
Next earnings date: 7/30/2025